Noninvasive Algorithms for the Case Finding of “At-Risk” Patients with NAFLD - Université d'Angers Accéder directement au contenu
Article Dans Une Revue Seminars in Liver Disease Année : 2022

Noninvasive Algorithms for the Case Finding of “At-Risk” Patients with NAFLD

Résumé

Despite the high prevalence of non-alcoholic fatty liver disease (NAFLD) in primary care (25%), only a small minority (< 5%) of NAFLD patients will develop advanced liver fibrosis. The challenge is to identify these patients, who are at the greatest risk of developing complications and need to be referred to liver clinics for specialized management. The focus should change from patients with abnormal liver tests toward patients “at risk of NAFLD,” namely those with metabolic risk factors, such as obesity and type 2 diabetes. Non-invasive tests are well validated for diagnosing advanced fibrosis. Algorithms using FIB-4 as the first-line test, followed, if positive (≥ 1.3), by transient elastography or a patented blood test are the best strategy to define pathways for “at-risk” NAFLD patients from primary care to liver clinics. Involving general practitioners actively and raising their awareness regarding NAFLD and non-invasive tests are critical to establish such pathways.
Fichier non déposé

Dates et versions

hal-03789207 , version 1 (27-09-2022)

Identifiants

Citer

Laurent Castera, Jérôme Boursier. Noninvasive Algorithms for the Case Finding of “At-Risk” Patients with NAFLD. Seminars in Liver Disease, 2022, 42 (03), pp.313-326. ⟨10.1055/s-0042-1751081⟩. ⟨hal-03789207⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More